Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The American Thrombosis and Hemostasis Network (ATHN) is a non-profit organization that provides the essential data infrastructure for the bleeding and clotting disorders community in the United States. By partnering with over 140 federally funded Hemophilia Treatment Centers (HTCs), ATHN maintains a secure national database known as the ATHN Dataset, which aggregates clinical data to support research and quality improvement. The organization facilitates large-scale clinical trials and public health surveillance in collaboration with the CDC and HRSA. Their platform enables researchers to analyze treatment outcomes and safety data for rare hematologic conditions. ATHN's work is critical for advancing the standard of care and supporting the development of new therapeutic strategies, including gene therapies, for patients with lifelong blood disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Thrombosis and Hemostasis Network.